Omer Asik's 2016-17 campaign was a disaster, as he played in a career-low 31 games. That was largely a result of a bacterial infection that eventually had him shut down for the season, but could also be attributed to the Pelicans shift towards a more athletic option at center. They ended up bringing over superstar DeMarcus Cousins in a trade at the deadline in February, which all but eliminated Asik from the rotation that he was already falling out of. That's not expected to change much going into the 2017-18 season. Cousins is still on board as the starting center and should command the bulk of the workload, while Anthony Davis will also see time at the position. That leaves Asik battling for reserve minutes with Alexis Ajinca, which isn't going to afford him much time on the floor. After averaging just 2.7 points and 5.3 rebounds across 15.5 minutes a season prior, there's a chance those continue to fall in Asik's eighth season.
Asik is currently being treated for Crohn's disease and remains without a timetable for a return, Jim Eichenhofer of Pelicans.com reports. Asik was limited to 31 games last season due to a bacterial infection and he's now been diagnosed with Crohn's disease. While GM Dell Demps said there's been some improvements with Asik's health, he also mentioned that "he's not ready to play basketball", so it appears Asik could still be out for quite some time. For now, it seems unlikely he'll be ready for the start of the season, though further word on his availability should be released as he progresses in his recovery.
Coach Alvin Gentry acknowledged Friday that Asik (illness) is likely to miss the remainder of the regular season, ESPN.com's Justin Verrier reports. "[Asik] will be gearing toward the summer and next year, really," Gentry said. Asik has been held out since the All-Star break while recovering from a bacterial infection, which caused him to shed a significant amount of weight. It seems Asik is still having difficultly getting back in playing condition, and because the Pelicans haven't been relying on him as a rotation player since late December, there's little incentive to rush him back before the campaign draws to a close in mid-April. Asik, who still has three years remaining on the five-year, $57.7 million pact he inked with the Pelicans in July of 2015, averaged 2.7 points and 5.3 rebounds in 15.5 minutes per game over 31 appearances in 2016-17.
Asik has been ruled out for Friday's game against the Rockets. Asik is still dealing with the lingering effects of a bacterial infection and will miss yet another game. He's yet to be given any timetable for a return and should continue to be evaluated on a game-to-game basis until the Pelicans suggest otherwise. He won't be included in coach Alvin Gentry's rotation once he returns to full strength.
Asik (illness) has been ruled out for Tuesday's tilt with the Grizzlies. Asik continues to miss time as he recovers from a bacterial infection which has sidelined him since the All-Star break. His next opportunity to take the court will come Thursday against the Rockets. When he is cleared to return, the center will likely play in an extremely limited role.
Asik (illness) is listed as out for Sunday's game against the Timberwolves, John Reid of the New Orleans Times-Picayune reports. Asik has been sidelined since the All-Star break while recovering from a bacterial infection. It's uncertain when the Pelicans can expect him to back at full health, but Asik won't be under consideration for a rotation spot for coach Alvin Gentry in any event.
Last 7 Games
|3 Year Avg||58||116||51.8||0||0.0||72||57.6||304||5.24||812|